The Cell & Gene Meeting on the Mesa stands as the major annual conference in the industry, bringing together esteemed senior executives and top decision-makers to drive cutting-edge research in pursuing transformative cures. This groundbreaking event is dedicated to overcoming the commercialization challenges the cell and gene therapy sector faces.
With an extensive range of topics covered, from clinical trial design to alternative payment models, scale-up, and supply chain platforms for advanced therapies, this meeting offers a comprehensive platform to address the industry’s most pressing issues and foster innovation.
The program boasts expert-led panels, facilitating insightful discussions and valuable knowledge sharing. Moreover, the event offers unparalleled partnering capabilities, creating opportunities for collaborative endeavors that push the boundaries of the field.
Engage with the industry’s trailblazers during exclusive networking opportunities and gain invaluable insights from over 100 dedicated presentations by leading publicly traded and privately held companies. This unique platform is designed to empower participants with the latest advancements and trends in the cell and gene therapy space.
As a Platinum sponsor, ARMI | BioFabUSA is deeply committed to advancing the frontiers of science and innovation. We are thrilled to support this transformative event and contribute to the collective effort of propelling the field forward.
Join us at the 2023 Meeting on the Mesa and be a part of this extraordinary gathering of industry leaders, visionaries, and trailblazers. Visit the conference website to learn more and secure your place at the forefront of cell and gene therapy innovation!
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
